Skip to main content
Book cover

Medical Imaging in Clinical Trials

  • Book
  • © 2014

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Overview and Trial Management

  2. Therapeutic Specifics of Medical Imaging

  3. The Future of Imaging in Clinical Trials

Keywords

About this book

In the last few years the use of medical imaging has increased exponentially in routine clinical practice. This has been reflected in a rapidly increasing use of medical imaging in clinical trials, through all phases. More recently this has culminated in a number of inter-disciplinary meetings with the various stake holders, including the FDA. Changes in the regulatory process has resulted, when it comes to the submission of data to the FDA, in a therapeutic agent where one or more of the trial end-points is the assessment of a radiological end-point. No longer is it sufficient to have the images read by the local investigator site.

The FDA has also identified Medical Imaging as one of the key 6 points in the Critical Path initiative which was launched in 2004. This puts a keen focus on the role of imaging and the need to clearly identify and understand this aspect of clinical trials.

As the pharmaceutical, biotech and medical device industry continues to identify ways to improve and speed up product development, medical imaging plays a more significant role. An understanding of the methodology and the metrics is therefore required but difficult to ascertain in one easy to read volume for individuals entering this field. This book will therefore fulfill this void, be it for the pharmaceutical personnel from medical director to monitor, or the Principal Investigator who is having to understand the complexities of the imaging and why it is having to be sent off-site for a 'central read.'

Reviews

“Chapters are well organized throughout the book and provide detailed information. The chosen didactic style creates an easy-to-follow flow of information throughout the chapters. The book fulfills its goal of providing the key concepts of medical imaging applied in clinical trials. … Multidisciplinary clinical trial teams will enjoy the readily comprehensible information, carefully selected didactic elements, and excellent quality of illustrations.” (Peter Reimer, Radiology, Vol. 275 (2), May, 2015)

Editors and Affiliations

  • Medical Affairs, BioClinica Inc., Newtown, USA

    Colin G. Miller

  • Department of Strategy and Regulatory Affairs, TherapeuticsMD, Boca Raton, USA

    Joel Krasnow

  • Dept. of Radiology, Columbia University Medical Center, New York, USA

    Lawrence H. Schwartz

Bibliographic Information

Publish with us